Rothschild Investment LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$515K Sell
9,374
-251
-3% -$13.8K 0.03% 333
2025
Q1
$680K Sell
9,625
-105
-1% -$7.42K 0.05% 282
2024
Q4
$640K Sell
9,730
-1,124
-10% -$73.9K 0.04% 299
2024
Q3
$763K Sell
10,854
-150
-1% -$10.5K 0.05% 274
2024
Q2
$906K Sell
11,004
-3,210
-23% -$264K 0.06% 239
2024
Q1
$1.24M Buy
14,214
+210
+1% +$18.3K 0.09% 198
2023
Q4
$1.35M Sell
14,004
-300
-2% -$28.9K 0.11% 155
2023
Q3
$1.27M Sell
14,304
-700
-5% -$62K 0.11% 177
2023
Q2
$1.3M Sell
15,004
-151
-1% -$13.1K 0.11% 183
2023
Q1
$1.47M Sell
15,155
-99
-0.6% -$9.63K 0.13% 158
2022
Q4
$1.58M Sell
15,254
-406
-3% -$42K 0.15% 148
2022
Q3
$1.33M Buy
15,660
+56
+0.4% +$4.75K 0.13% 163
2022
Q2
$1.29M Buy
15,604
+1,050
+7% +$87K 0.12% 177
2022
Q1
$1.12M Hold
14,554
0.09% 212
2021
Q4
$1.29M Buy
14,554
+481
+3% +$42.5K 0.1% 192
2021
Q3
$1.09M Sell
14,073
-300
-2% -$23.2K 0.09% 211
2021
Q2
$1.2M Sell
14,373
-425
-3% -$35.5K 0.1% 199
2021
Q1
$1.12M Buy
14,798
+200
+1% +$15.1K 0.1% 205
2020
Q4
$1.28M Buy
14,598
+162
+1% +$14.2K 0.12% 167
2020
Q3
$1.1M Sell
14,436
-2,880
-17% -$219K 0.12% 163
2020
Q2
$2.14M Sell
17,316
-993
-5% -$122K 0.26% 99
2020
Q1
$1.55M Sell
18,309
-410
-2% -$34.6K 0.2% 119
2019
Q4
$1.58M Buy
18,719
+1,500
+9% +$127K 0.16% 145
2019
Q3
$1.16M Sell
17,219
-400
-2% -$27K 0.14% 149
2019
Q2
$1.51M Buy
17,619
+4,585
+35% +$393K 0.18% 129
2019
Q1
$1.16M Buy
13,034
+100
+0.8% +$8.88K 0.14% 158
2018
Q4
$1.1M Sell
12,934
-100
-0.8% -$8.51K 0.15% 136
2018
Q3
$1.26M Sell
13,034
-665
-5% -$64.5K 0.15% 144
2018
Q2
$1.29M Hold
13,699
0.16% 140
2018
Q1
$1.11M Buy
13,699
+6,330
+86% +$513K 0.14% 154
2017
Q4
$657K Buy
+7,369
New +$657K 0.07% 242